Inside Germany’s biotech capital infrastructure and innovation engine
In this episode of Denatured, as part of our series of the European life science investment ecosystem, you'll be hearing from Regina Hodits, managing director at Angelini Ventures and Sofia Ioannidou, VC partner at Andera Life Sciences. They examine Germany’s biotech and life sciences landscape, focusing on the scientific, infrastructure and policy shifts required to enable European companies to scale globally while remaining anchored in Europe.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Regina Hodits, Managing Director, Angelini Ventures
Sofia Ioannidou, VC…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.